Inhibiting the action of ERα with selective estrogen receptor modulators (SERMs) or selective estrogen receptor degraders (SERDs), or reducing endogenous estrogen levels with aromatase inhibitors (AI), are effective treatments for many of these breast cancers (Strasser-Weippl and Goss, 2005). The gene discussed is ESR1; the disease is breast cancer.